Overview

Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH

Status:
Completed
Trial end date:
2017-08-23
Target enrollment:
Participant gender:
Summary
The trial will compare a twice-monthly somavaratan dosing regimen for non-inferiority of treatment effect against daily injections of rhGH.
Phase:
Phase 3
Details
Lead Sponsor:
Versartis Inc.
Treatments:
Hormones